Automated synthesis enhances lesion detection in neuroendocrine neoplasms, suggesting improved imaging quality.
A robust, GMP-compatible automated synthesis process for [¹⁸F]AlF-NOTA-Octreotide and a lyophilized kit for [⁶⁸Ga]Ga-NOTA-Octreotide were successfully established, both exhibiting high RCP, high specific activity, and excellent stability. [¹⁸F]AlF-NOTA-Octreotide demonstrated significantly higher lesion detection rates and uptake intensity than [¹⁸F]FDG in SSTR2-positive NENs with lower background activity. The complementary profiles of these probes enable personalized, precise imaging based on tumor biology. This work provides substantial technical and data support for clinical translation.
No takes yet. Share an insight, caveat, or question.
Wan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: